[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Embolization in Interventional Oncology Market - Global Outlook and Forecast 2021-2027

April 2021 | 90 pages | ID: E227DF02C07EEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Embolization in Interventional Oncology in Global, including the following market information:

Global Embolization in Interventional Oncology Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Embolization in Interventional Oncology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Embolization in Interventional Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Embolization in Interventional Oncology Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Embolization in Interventional Oncology Market Segment Percentages, By Type, 2020 (%)
  • Embolization Devices
  • Ablation Devices
  • Support Devices
China Embolization in Interventional Oncology Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Embolization in Interventional Oncology Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Specialty Clinics
Global Embolization in Interventional Oncology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Embolization in Interventional Oncology Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Embolization in Interventional Oncology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Embolization in Interventional Oncology Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Braile Biomedica
  • Boston Scientific
  • Cook Medical
  • Covidien
  • Merit Medical Systems, Inc.
  • Penumbra
  • TERUMO MEDICAL CORPORATION
  • Stryker
  • Terumo
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Embolization in Interventional Oncology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Embolization in Interventional Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EMBOLIZATION IN INTERVENTIONAL ONCOLOGY OVERALL MARKET SIZE

2.1 Global Embolization in Interventional Oncology Market Size: 2021 VS 2027
2.2 Global Embolization in Interventional Oncology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Embolization in Interventional Oncology Players in Global Market
3.2 Top Global Embolization in Interventional Oncology Companies Ranked by Revenue
3.3 Global Embolization in Interventional Oncology Revenue by Companies
3.4 Top 3 and Top 5 Embolization in Interventional Oncology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Embolization in Interventional Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Embolization in Interventional Oncology Players in Global Market
  3.6.1 List of Global Tier 1 Embolization in Interventional Oncology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Embolization in Interventional Oncology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Embolization in Interventional Oncology Market Size Markets, 2021 & 2027
  4.1.2 Embolization Devices
  4.1.3 Ablation Devices
  4.1.4 Support Devices
4.2 By Type - Global Embolization in Interventional Oncology Revenue & Forecasts
  4.2.1 By Type - Global Embolization in Interventional Oncology Revenue, 2016-2021
  4.2.2 By Type - Global Embolization in Interventional Oncology Revenue, 2022-2027
  4.2.3 By Type - Global Embolization in Interventional Oncology Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Embolization in Interventional Oncology Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
5.2 By Application - Global Embolization in Interventional Oncology Revenue & Forecasts
  5.2.1 By Application - Global Embolization in Interventional Oncology Revenue, 2016-2021
  5.2.2 By Application - Global Embolization in Interventional Oncology Revenue, 2022-2027
  5.2.3 By Application - Global Embolization in Interventional Oncology Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Embolization in Interventional Oncology Market Size, 2021 & 2027
6.2 By Region - Global Embolization in Interventional Oncology Revenue & Forecasts
  6.2.1 By Region - Global Embolization in Interventional Oncology Revenue, 2016-2021
  6.2.2 By Region - Global Embolization in Interventional Oncology Revenue, 2022-2027
  6.2.3 By Region - Global Embolization in Interventional Oncology Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Embolization in Interventional Oncology Revenue, 2016-2027
  6.3.2 US Embolization in Interventional Oncology Market Size, 2016-2027
  6.3.3 Canada Embolization in Interventional Oncology Market Size, 2016-2027
  6.3.4 Mexico Embolization in Interventional Oncology Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Embolization in Interventional Oncology Revenue, 2016-2027
  6.4.2 Germany Embolization in Interventional Oncology Market Size, 2016-2027
  6.4.3 France Embolization in Interventional Oncology Market Size, 2016-2027
  6.4.4 U.K. Embolization in Interventional Oncology Market Size, 2016-2027
  6.4.5 Italy Embolization in Interventional Oncology Market Size, 2016-2027
  6.4.6 Russia Embolization in Interventional Oncology Market Size, 2016-2027
  6.4.7 Nordic Countries Embolization in Interventional Oncology Market Size, 2016-2027
  6.4.8 Benelux Embolization in Interventional Oncology Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Embolization in Interventional Oncology Revenue, 2016-2027
  6.5.2 China Embolization in Interventional Oncology Market Size, 2016-2027
  6.5.3 Japan Embolization in Interventional Oncology Market Size, 2016-2027
  6.5.4 South Korea Embolization in Interventional Oncology Market Size, 2016-2027
  6.5.5 Southeast Asia Embolization in Interventional Oncology Market Size, 2016-2027
  6.5.6 India Embolization in Interventional Oncology Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Embolization in Interventional Oncology Revenue, 2016-2027
  6.6.2 Brazil Embolization in Interventional Oncology Market Size, 2016-2027
  6.6.3 Argentina Embolization in Interventional Oncology Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Embolization in Interventional Oncology Revenue, 2016-2027
  6.7.2 Turkey Embolization in Interventional Oncology Market Size, 2016-2027
  6.7.3 Israel Embolization in Interventional Oncology Market Size, 2016-2027
  6.7.4 Saudi Arabia Embolization in Interventional Oncology Market Size, 2016-2027
  6.7.5 UAE Embolization in Interventional Oncology Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Braile Biomedica
  7.1.1 Braile Biomedica Corporate Summary
  7.1.2 Braile Biomedica Business Overview
  7.1.3 Braile Biomedica Embolization in Interventional Oncology Major Product Offerings
  7.1.4 Braile Biomedica Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.1.5 Braile Biomedica Key News
7.2 Boston Scientific
  7.2.1 Boston Scientific Corporate Summary
  7.2.2 Boston Scientific Business Overview
  7.2.3 Boston Scientific Embolization in Interventional Oncology Major Product Offerings
  7.2.4 Boston Scientific Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.2.5 Boston Scientific Key News
7.3 Cook Medical
  7.3.1 Cook Medical Corporate Summary
  7.3.2 Cook Medical Business Overview
  7.3.3 Cook Medical Embolization in Interventional Oncology Major Product Offerings
  7.3.4 Cook Medical Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.3.5 Cook Medical Key News
7.4 Covidien
  7.4.1 Covidien Corporate Summary
  7.4.2 Covidien Business Overview
  7.4.3 Covidien Embolization in Interventional Oncology Major Product Offerings
  7.4.4 Covidien Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.4.5 Covidien Key News
7.5 Merit Medical Systems, Inc.
  7.5.1 Merit Medical Systems, Inc. Corporate Summary
  7.5.2 Merit Medical Systems, Inc. Business Overview
  7.5.3 Merit Medical Systems, Inc. Embolization in Interventional Oncology Major Product Offerings
  7.5.4 Merit Medical Systems, Inc. Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.5.5 Merit Medical Systems, Inc. Key News
7.6 Penumbra
  7.6.1 Penumbra Corporate Summary
  7.6.2 Penumbra Business Overview
  7.6.3 Penumbra Embolization in Interventional Oncology Major Product Offerings
  7.6.4 Penumbra Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.6.5 Penumbra Key News
7.7 TERUMO MEDICAL CORPORATION
  7.7.1 TERUMO MEDICAL CORPORATION Corporate Summary
  7.7.2 TERUMO MEDICAL CORPORATION Business Overview
  7.7.3 TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Major Product Offerings
  7.4.4 TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.7.5 TERUMO MEDICAL CORPORATION Key News
7.8 Stryker
  7.8.1 Stryker Corporate Summary
  7.8.2 Stryker Business Overview
  7.8.3 Stryker Embolization in Interventional Oncology Major Product Offerings
  7.8.4 Stryker Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.8.5 Stryker Key News
7.9 Terumo
  7.9.1 Terumo Corporate Summary
  7.9.2 Terumo Business Overview
  7.9.3 Terumo Embolization in Interventional Oncology Major Product Offerings
  7.9.4 Terumo Embolization in Interventional Oncology Revenue in Global (2016-2021)
  7.9.5 Terumo Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Embolization in Interventional Oncology Market Opportunities & Trends in Global Market
Table 2. Embolization in Interventional Oncology Market Drivers in Global Market
Table 3. Embolization in Interventional Oncology Market Restraints in Global Market
Table 4. Key Players of Embolization in Interventional Oncology in Global Market
Table 5. Top Embolization in Interventional Oncology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Embolization in Interventional Oncology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Embolization in Interventional Oncology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Embolization in Interventional Oncology Product Type
Table 9. List of Global Tier 1 Embolization in Interventional Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Embolization in Interventional Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Embolization in Interventional Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Embolization in Interventional Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Embolization in Interventional Oncology Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Embolization in Interventional Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Embolization in Interventional Oncology Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Embolization in Interventional Oncology Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Embolization in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Embolization in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Embolization in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Embolization in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Embolization in Interventional Oncology Revenue, (US$, Mn), 2022-2027
Table 30. Braile Biomedica Corporate Summary
Table 31. Braile Biomedica Embolization in Interventional Oncology Product Offerings
Table 32. Braile Biomedica Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 33. Boston Scientific Corporate Summary
Table 34. Boston Scientific Embolization in Interventional Oncology Product Offerings
Table 35. Boston Scientific Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 36. Cook Medical Corporate Summary
Table 37. Cook Medical Embolization in Interventional Oncology Product Offerings
Table 38. Cook Medical Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 39. Covidien Corporate Summary
Table 40. Covidien Embolization in Interventional Oncology Product Offerings
Table 41. Covidien Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 42. Merit Medical Systems, Inc. Corporate Summary
Table 43. Merit Medical Systems, Inc. Embolization in Interventional Oncology Product Offerings
Table 44. Merit Medical Systems, Inc. Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 45. Penumbra Corporate Summary
Table 46. Penumbra Embolization in Interventional Oncology Product Offerings
Table 47. Penumbra Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 48. TERUMO MEDICAL CORPORATION Corporate Summary
Table 49. TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Product Offerings
Table 50. TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 51. Stryker Corporate Summary
Table 52. Stryker Embolization in Interventional Oncology Product Offerings
Table 53. Stryker Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)
Table 54. Terumo Corporate Summary
Table 55. Terumo Embolization in Interventional Oncology Product Offerings
Table 56. Terumo Embolization in Interventional Oncology Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Embolization in Interventional Oncology Segment by Type
Figure 2. Embolization in Interventional Oncology Segment by Application
Figure 3. Global Embolization in Interventional Oncology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Embolization in Interventional Oncology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Embolization in Interventional Oncology Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Embolization in Interventional Oncology Revenue in 2020
Figure 8. By Type - Global Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 9. By Application - Global Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 10. By Region - Global Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 11. By Country - North America Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 12. US Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 16. Germany Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 17. France Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 24. China Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 28. India Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 30. Brazil Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Embolization in Interventional Oncology Revenue Market Share, 2016-2027
Figure 33. Turkey Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Embolization in Interventional Oncology Revenue, (US$, Mn), 2016-2027
Figure 37. Braile Biomedica Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Boston Scientific Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Cook Medical Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Covidien Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Merit Medical Systems, Inc. Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Penumbra Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. TERUMO MEDICAL CORPORATION Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Stryker Embolization in Interventional Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications